Estuary Biotherapeutics · Seed
Charting a new course for patients with kidney disease by developing targeted gene therapies for ADPKD.
Amount
$10M
Round
Seed
Valuation
—
Announced
Oct 2026
Notes
auto-discovered via firecrawl
Other Estuary Biotherapeutics rounds
| Date | Round | Amount | |
|---|---|---|---|
| Oct 2026 | Series A | $93M | Details → |